The insulin in dosage market size in Ireland experienced varying trends over the past decade, standing at 58.009 million USD in 2023. Following a decreasing pattern from 2013 to 2016, it rebounded, peaking in 2021. However, in recent years, it faced declines in 2022 and almost stagnant growth in 2023, with a year-on-year variation of -0.15%. The past five-year CAGR mirrors these fluctuations, averaging at -0.85%.
Looking ahead, trends to watch include:
- Advancements in insulin delivery technologies.
- Emergence of alternative therapies affecting insulin demand.
- Market adaptations to regulatory changes in healthcare policies.
- Potential impact of biosimilar insulin adoption on pricing and market share.
How does Ireland rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 18 | 18 New Zealand | 81,840,000 | 2023 | +5.78% | +2.26% | View data |
| 19 | 19 Slovakia | 72,785,000 | 2023 | -0.13% | +0.52% | View data |
| 20 | 20 Ireland | 58,009,000 | 2023 | -0.15% | -0.85% | |
| 21 | 21 Switzerland | 53,245,000 | 2023 | -2.3% | -1.88% | View data |
| 22 | 22 Morocco | 42,235,000 | 2023 | +1.18% | +1.18% | View data |
